{"ticker": "MNLO", "overview": {"cik": "1566044", "ticker": "YARW", "name": "Yarrow Bioscience, Inc.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "SCHEDULE 13G", "date": "2026-10-07", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-114282", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-09-17", "title": "Form SCHEDULE 13G", "accession": "0002005369-26-000053", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-14", "title": "FORM 8-K", "accession": "0001104659-26-107485", "price_sensitive": true}, {"form": "424B5", "date": "2026-09-11", "title": "Prospectus", "accession": "0001104659-26-107112", "price_sensitive": false}, {"form": "424B5", "date": "2026-09-11", "title": "Prospectus", "accession": "0001104659-26-107102", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-10", "title": "FORM 8-K", "accession": "0001104659-26-106699", "price_sensitive": true}, {"form": "EFFECT", "date": "2026-08-19", "title": "Form EFFECT", "accession": "9999999995-26-002706", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-14", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-097426", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-14", "title": "Form SCHEDULE 13G", "accession": "0000905148-26-003761", "price_sensitive": false}, {"form": "POS AM", "date": "2026-08-14", "title": "Form POS AM", "accession": "0001104659-26-096109", "price_sensitive": false}, {"form": "8-K/A", "date": "2026-08-13", "title": "FORM 8-K/A", "accession": "0001104659-26-095925", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-13", "title": "Quarterly report", "accession": "0001566044-26-000010", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-08-13", "title": "Form SCHEDULE 13G/A", "accession": "0002140685-26-000004", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-07", "title": "Form SCHEDULE 13G/A", "accession": "0000935836-26-000377", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-07", "title": "Form SCHEDULE 13G", "accession": "0001274173-26-000185", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-08-05", "title": "Form SCHEDULE 13D", "accession": "0000947871-26-000747", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-04", "title": "Form SCHEDULE 13G", "accession": "0000935836-26-000371", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-03", "title": "Form SCHEDULE 13G", "accession": "0001193125-26-330498", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-07-30", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-088671", "price_sensitive": false}, {"form": "4", "date": "2026-07-30", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088665", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-30", "title": "FORM 8-K", "accession": "0001104659-26-088662", "price_sensitive": true}, {"form": "3", "date": "2026-07-30", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088658", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088371", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088370", "price_sensitive": false}, {"form": "3", "date": "2026-07-29", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088369", "price_sensitive": false}]}, "description": "", "exchange": null, "stats": {"buy_n": 4, "buy_sum": 16700010.7, "sell_n": 1, "sell_sum": 3825000.0, "net": 12875010.7, "insiders": 5, "first_date": "2018-01-25", "last_date": "2020-06-09"}, "metrics": {"ticker": "MNLO", "has_prices": false}, "trades": [{"id": "0001209191-20-047960", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Sharon Barbari", "who_key": "BARBARI SHARON", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 111000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120047960/0001209191-20-047960-index.htm", "trade_date": "2020-08-20", "timestamp": "2020-08-20", "mins": 3262540}, {"id": "0001209191-20-045128", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Sharon Barbari", "who_key": "BARBARI SHARON", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120045128/0001209191-20-045128-index.htm", "trade_date": "2020-08-03", "timestamp": "2020-08-03", "mins": 3287020}, {"id": "0001209191-20-045129", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Steven L. Basta", "who_key": "Basta Steven L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120045129/0001209191-20-045129-index.htm", "trade_date": "2020-08-03", "timestamp": "2020-08-03", "mins": 3287020}, {"id": "0001209191-20-045130", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Anthony D. Bruno", "who_key": "Bruno Anthony D", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120045130/0001209191-20-045130-index.htm", "trade_date": "2020-08-03", "timestamp": "2020-08-03", "mins": 3287020}, {"id": "0001209191-20-045135", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Rex Bright", "who_key": "Bright Rex", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120045135/0001209191-20-045135-index.htm", "trade_date": "2020-08-03", "timestamp": "2020-08-03", "mins": 3287020}, {"id": "0001209191-20-040293", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "David Domzalski", "who_key": "Domzalski David", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 10793.47, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120040293/0001209191-20-040293-index.htm", "trade_date": "2020-06-30", "timestamp": "2020-06-30", "mins": 3335980}, {"id": "0001209191-20-040306", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Iain Stuart", "who_key": "Stuart Iain", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 4113.94, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120040306/0001209191-20-040306-index.htm", "trade_date": "2020-06-30", "timestamp": "2020-06-30", "mins": 3335980}, {"id": "0001209191-20-040308", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Matthew T. Wiley", "who_key": "Wiley Matthew T.", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 2665.93, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120040308/0001209191-20-040308-index.htm", "trade_date": "2020-06-30", "timestamp": "2020-06-30", "mins": 3335980}, {"id": "0000899243-20-016198", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Perceptive Advisors LLC", "who_key": "PERCEPTIVE ADVISORS LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 4999998.7, "score": 58.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "MNLO's biggest backer adds $5M", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000089924320016198/0000899243-20-016198-index.htm", "trade_date": "2020-06-09", "timestamp": "2020-06-09", "mins": 3366220}, {"id": "0001209191-20-028034", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "David Domzalski", "who_key": "Domzalski David", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120028034/0001209191-20-028034-index.htm", "trade_date": "2020-05-06", "timestamp": "2020-05-06", "mins": 3415180}, {"id": "0001209191-20-028036", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Mutya Harsch", "who_key": "Harsch Mutya", "role": "Chief Legal Officer and GC", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120028036/0001209191-20-028036-index.htm", "trade_date": "2020-05-06", "timestamp": "2020-05-06", "mins": 3415180}, {"id": "0001209191-20-028037", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Andrew Saik", "who_key": "Saik Andrew", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120028037/0001209191-20-028037-index.htm", "trade_date": "2020-05-06", "timestamp": "2020-05-06", "mins": 3415180}, {"id": "0001209191-20-028038", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Iain Stuart", "who_key": "Stuart Iain", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120028038/0001209191-20-028038-index.htm", "trade_date": "2020-05-06", "timestamp": "2020-05-06", "mins": 3415180}, {"id": "0001209191-20-023804", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "David Domzalski", "who_key": "Domzalski David", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 16480.8, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120023804/0001209191-20-023804-index.htm", "trade_date": "2020-04-06", "timestamp": "2020-04-06", "mins": 3458380}, {"id": "0001209191-20-023805", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Mutya Harsch", "who_key": "Harsch Mutya", "role": "Chief Legal Officer and GC", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 6263.599999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120023805/0001209191-20-023805-index.htm", "trade_date": "2020-04-06", "timestamp": "2020-04-06", "mins": 3458380}, {"id": "0001209191-20-023810", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Iain Stuart", "who_key": "Stuart Iain", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 5268.2, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120023810/0001209191-20-023810-index.htm", "trade_date": "2020-04-06", "timestamp": "2020-04-06", "mins": 3458380}, {"id": "0001209191-20-023813", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Matthew T. Wiley", "who_key": "Wiley Matthew T.", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 1271.1999999999998, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120023813/0001209191-20-023813-index.htm", "trade_date": "2020-04-06", "timestamp": "2020-04-06", "mins": 3458380}, {"id": "0001209191-20-023799", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Steven L. Basta", "who_key": "Basta Steven L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120023799/0001209191-20-023799-index.htm", "trade_date": "2020-04-03", "timestamp": "2020-04-03", "mins": 3462700}, {"id": "0001209191-20-023803", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Anthony D. Bruno", "who_key": "Bruno Anthony D", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120023803/0001209191-20-023803-index.htm", "trade_date": "2020-04-03", "timestamp": "2020-04-03", "mins": 3462700}, {"id": "0001209191-20-023807", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Stanley Hirsch", "who_key": "Hirsch Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120023807/0001209191-20-023807-index.htm", "trade_date": "2020-04-03", "timestamp": "2020-04-03", "mins": 3462700}, {"id": "0001209191-20-022574", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "David Domzalski", "who_key": "Domzalski David", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 11942.08, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120022574/0001209191-20-022574-index.htm", "trade_date": "2020-03-31", "timestamp": "2020-03-31", "mins": 3467020}, {"id": "0001209191-20-022591", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Matthew T. Wiley", "who_key": "Wiley Matthew T.", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 1407.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120022591/0001209191-20-022591-index.htm", "trade_date": "2020-03-31", "timestamp": "2020-03-31", "mins": 3467020}, {"id": "0001209191-20-020935", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Andrew Saik", "who_key": "Saik Andrew", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120020935/0001209191-20-020935-index.htm", "trade_date": "2020-03-23", "timestamp": "2020-03-23", "mins": 3478540}, {"id": "0001209191-20-020656", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Sharon Surrey Barbari", "who_key": "BARBARI SHARON SURREY", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120020656/0001209191-20-020656-index.htm", "trade_date": "2020-03-19", "timestamp": "2020-03-19", "mins": 3484300}, {"id": "0001209191-20-020657", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Steven L. Basta", "who_key": "Basta Steven L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120020657/0001209191-20-020657-index.htm", "trade_date": "2020-03-19", "timestamp": "2020-03-19", "mins": 3484300}, {"id": "0001209191-20-020659", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Rex Bright", "who_key": "Bright Rex", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120020659/0001209191-20-020659-index.htm", "trade_date": "2020-03-19", "timestamp": "2020-03-19", "mins": 3484300}, {"id": "0001209191-20-020660", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Anthony D. Bruno", "who_key": "Bruno Anthony D", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120020660/0001209191-20-020660-index.htm", "trade_date": "2020-03-19", "timestamp": "2020-03-19", "mins": 3484300}, {"id": "0001209191-20-020663", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Elisabeth Sandoval", "who_key": "Sandoval Elisabeth", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120020663/0001209191-20-020663-index.htm", "trade_date": "2020-03-19", "timestamp": "2020-03-19", "mins": 3484300}, {"id": "0001209191-20-018220", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Sharon Surrey Barbari", "who_key": "BARBARI SHARON SURREY", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120018220/0001209191-20-018220-index.htm", "trade_date": "2020-03-09", "timestamp": "2020-03-09", "mins": 3498700}, {"id": "0001209191-20-018221", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Steven L. Basta", "who_key": "Basta Steven L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on MNLO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919120018221/0001209191-20-018221-index.htm", "trade_date": "2020-03-09", "timestamp": "2020-03-09", "mins": 3498700}], "recent_buys": [{"id": "0000899243-20-016198", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics Inc.", "who": "Perceptive Advisors LLC", "who_key": "PERCEPTIVE ADVISORS LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 4999998.7, "score": 58.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "MNLO's biggest backer adds $5M", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000089924320016198/0000899243-20-016198-index.htm", "trade_date": "2020-06-09", "timestamp": "2020-06-09", "mins": 3366220}, {"id": "0001209191-18-005831", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics, Inc.", "who": "Remeditex Ventures LLC", "who_key": "Remeditex Ventures LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 1700000.0, "score": 52.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Big holder adds $1.7M of MNLO", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919118005831/0001209191-18-005831-index.htm", "trade_date": "2018-01-25", "timestamp": "2018-01-25", "mins": 4613260}, {"id": "0001209191-18-005829", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics, Inc.", "who": "Vivo Capital VIII, LLC", "who_key": "Vivo Capital VIII, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 5000006.0, "score": 56.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 3 buying MNLO", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919118005829/0001209191-18-005829-index.htm", "trade_date": "2018-01-25", "timestamp": "2018-01-25", "mins": 4613260}, {"id": "0001209191-18-005827", "src": "INSIDERS", "ticker": "MNLO", "cik": "1566044", "company": "Yarrow Bioscience, Inc.", "company_raw": "Menlo Therapeutics, Inc.", "who": "Albert Cha", "who_key": "Cha Albert", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 5000006.0, "score": 59.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "4 insiders now buying MNLO", "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919118005827/0001209191-18-005827-index.htm", "trade_date": "2018-01-25", "timestamp": "2018-01-25", "mins": 4613260}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Vivo Capital VIII, LLC", "who_key": "Vivo Capital VIII, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 5000006.0, "sold": 0, "net": 5000006.0, "trades": 1, "top_score": 56.9, "lean": "buying", "history": [{"action": "BUY", "amount": 5000006.0, "date": "2018-01-25", "score": 56.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919118005829/0001209191-18-005829-index.htm"}], "latest": {"action": "BUY", "amount": 5000006.0, "date": "2018-01-25", "score": 56.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919118005829/0001209191-18-005829-index.htm"}}, {"who": "Albert Cha", "who_key": "Cha Albert", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 5000006.0, "sold": 0, "net": 5000006.0, "trades": 1, "top_score": 59.4, "lean": "buying", "history": [{"action": "BUY", "amount": 5000006.0, "date": "2018-01-25", "score": 59.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919118005827/0001209191-18-005827-index.htm"}], "latest": {"action": "BUY", "amount": 5000006.0, "date": "2018-01-25", "score": 59.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919118005827/0001209191-18-005827-index.htm"}}, {"who": "Perceptive Advisors LLC", "who_key": "PERCEPTIVE ADVISORS LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 4999998.7, "sold": 0, "net": 4999998.7, "trades": 1, "top_score": 58.9, "lean": "buying", "history": [{"action": "BUY", "amount": 4999998.7, "date": "2020-06-09", "score": 58.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000089924320016198/0000899243-20-016198-index.htm"}], "latest": {"action": "BUY", "amount": 4999998.7, "date": "2020-06-09", "score": 58.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000089924320016198/0000899243-20-016198-index.htm"}}, {"who": "Presidio Partners 2007 GP, L.P.", "who_key": "Presidio Partners 2007 GP, L.P.", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "bought": 0, "sold": 3825000.0, "net": -3825000.0, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 3825000.0, "date": "2018-07-24", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000114420418040247/0001144204-18-040247-index.htm"}], "latest": {"action": "SELL", "amount": 3825000.0, "date": "2018-07-24", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000114420418040247/0001144204-18-040247-index.htm"}}, {"who": "Remeditex Ventures LLC", "who_key": "Remeditex Ventures LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 1700000.0, "sold": 0, "net": 1700000.0, "trades": 1, "top_score": 52.3, "lean": "buying", "history": [{"action": "BUY", "amount": 1700000.0, "date": "2018-01-25", "score": 52.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919118005831/0001209191-18-005831-index.htm"}], "latest": {"action": "BUY", "amount": 1700000.0, "date": "2018-01-25", "score": 52.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1566044/000120919118005831/0001209191-18-005831-index.htm"}}], "activity": [], "announcements": [{"form": "SCHEDULE 13G", "date": "2026-10-07", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-114282", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-09-17", "title": "Form SCHEDULE 13G", "accession": "0002005369-26-000053", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-14", "title": "FORM 8-K", "accession": "0001104659-26-107485", "price_sensitive": true}, {"form": "424B5", "date": "2026-09-11", "title": "Prospectus", "accession": "0001104659-26-107112", "price_sensitive": false}, {"form": "424B5", "date": "2026-09-11", "title": "Prospectus", "accession": "0001104659-26-107102", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-10", "title": "FORM 8-K", "accession": "0001104659-26-106699", "price_sensitive": true}, {"form": "EFFECT", "date": "2026-08-19", "title": "Form EFFECT", "accession": "9999999995-26-002706", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-14", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-097426", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-14", "title": "Form SCHEDULE 13G", "accession": "0000905148-26-003761", "price_sensitive": false}, {"form": "POS AM", "date": "2026-08-14", "title": "Form POS AM", "accession": "0001104659-26-096109", "price_sensitive": false}, {"form": "8-K/A", "date": "2026-08-13", "title": "FORM 8-K/A", "accession": "0001104659-26-095925", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-13", "title": "Quarterly report", "accession": "0001566044-26-000010", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-08-13", "title": "Form SCHEDULE 13G/A", "accession": "0002140685-26-000004", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-07", "title": "Form SCHEDULE 13G/A", "accession": "0000935836-26-000377", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-07", "title": "Form SCHEDULE 13G", "accession": "0001274173-26-000185", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-08-05", "title": "Form SCHEDULE 13D", "accession": "0000947871-26-000747", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-04", "title": "Form SCHEDULE 13G", "accession": "0000935836-26-000371", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-03", "title": "Form SCHEDULE 13G", "accession": "0001193125-26-330498", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-07-30", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-088671", "price_sensitive": false}, {"form": "4", "date": "2026-07-30", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088665", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-30", "title": "FORM 8-K", "accession": "0001104659-26-088662", "price_sensitive": true}, {"form": "3", "date": "2026-07-30", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088658", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088371", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088370", "price_sensitive": false}, {"form": "3", "date": "2026-07-29", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-088369", "price_sensitive": false}], "performance": {"ticker": "MNLO", "has_prices": false, "summary": null, "buys": [{"who": "PERCEPTIVE ADVISORS LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 4999998.7, "date": "2020-06-09", "score": 58.9, "ref_price": null, "return": null}, {"who": "Remeditex Ventures LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1700000.0, "date": "2018-01-25", "score": 52.3, "ref_price": null, "return": null}, {"who": "Vivo Capital VIII, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 5000006.0, "date": "2018-01-25", "score": 56.9, "ref_price": null, "return": null}, {"who": "Cha Albert", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 5000006.0, "date": "2018-01-25", "score": 59.4, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}